Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Sterckx

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Science and Engineering Ethics|February 25, 2005
Can drug patents be morally justified?Sigrid Sterckx
Science and Engineering Ethics|September 22, 2009
Patenting and licensing of university research: promoting innovation or undermining academic values?Sigrid Sterckx
Developing World Bioethics|April 17, 2004
Patents and access to drugs in developing countries: an ethical analysisSigrid Sterckx
Journal of Medical Ethics|January 26, 2013
The active recruitment of health workers: a commentarySigrid Sterckx
Expert Opinion on Therapeutic Patents|April 21, 2015
Does European patent law unfairly discriminate against medical devices as compared with pharmaceuticals?Sigrid Sterckx
Journal International De Bioethique = International Journal of Bioethics|October 18, 2007
Biodiversity under the law: protection or propertisation?Sigrid Sterckx
The American Journal of Bioethics : AJOB|March 26, 2020
Patenting Foundational Technologies: Recent Developments in the CRISPR Patent StruggleJulian Cockbain, Sigrid Sterckx
Expert Review of Molecular Diagnostics|March 17, 2011
Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?Julian Cockbain, Sigrid Sterckx
Medical Law Review|May 21, 2014
The UK National Health Service's 'innovation agenda': lessons on commercialisation and trustSigrid Sterckx, Julian Cockbain
Journal of Evaluation in Clinical Practice|December 30, 2015
How defining clinical practices may influence their evaluation: the case of continuous sedation at the end of lifeKasper Raus, Sigrid Sterckx
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Science and Engineering Ethics|February 25, 2005
Can drug patents be morally justified?Sigrid Sterckx
Science and Engineering Ethics|September 22, 2009
Patenting and licensing of university research: promoting innovation or undermining academic values?Sigrid Sterckx
Developing World Bioethics|April 17, 2004
Patents and access to drugs in developing countries: an ethical analysisSigrid Sterckx
Journal of Medical Ethics|January 26, 2013
The active recruitment of health workers: a commentarySigrid Sterckx
Expert Opinion on Therapeutic Patents|April 21, 2015
Does European patent law unfairly discriminate against medical devices as compared with pharmaceuticals?Sigrid Sterckx
Journal International De Bioethique = International Journal of Bioethics|October 18, 2007
Biodiversity under the law: protection or propertisation?Sigrid Sterckx
The American Journal of Bioethics : AJOB|March 26, 2020
Patenting Foundational Technologies: Recent Developments in the CRISPR Patent StruggleJulian Cockbain, Sigrid Sterckx
Expert Review of Molecular Diagnostics|March 17, 2011
Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?Julian Cockbain, Sigrid Sterckx
Medical Law Review|May 21, 2014
The UK National Health Service's 'innovation agenda': lessons on commercialisation and trustSigrid Sterckx, Julian Cockbain
Journal of Evaluation in Clinical Practice|December 30, 2015
How defining clinical practices may influence their evaluation: the case of continuous sedation at the end of lifeKasper Raus, Sigrid Sterckx
Pageof 8